Sientra (SIEN) Shares Up 6%
Sientra Inc (NASDAQ:SIEN) shot up 6% during trading on Friday . The stock traded as high as $8.97 and last traded at $8.84. 2,163,041 shares were traded during trading, an increase of 182% from the average session volume of 768,334 shares. The stock had previously closed at $8.34.
Several research firms recently commented on SIEN. Maxim Group reaffirmed a “buy” rating and set a $20.00 target price on shares of Sientra in a research note on Monday, February 11th. ValuEngine cut Sientra from a “strong-buy” rating to a “buy” rating in a research note on Thursday, January 24th. William Blair lowered Sientra from an “outperform” rating to a “market perform” rating in a report on Wednesday. Leerink Swann cut their price target on Sientra from $22.00 to $18.00 in a report on Wednesday. Finally, BidaskClub lowered Sientra from a “sell” rating to a “strong sell” rating in a report on Tuesday, December 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $20.44.
The firm has a market capitalization of $252.82 million, a PE ratio of -2.72 and a beta of -0.04. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.77 and a quick ratio of 2.34.
Hedge funds have recently bought and sold shares of the company. Alliancebernstein L.P. lifted its holdings in shares of Sientra by 18.8% in the third quarter. Alliancebernstein L.P. now owns 21,500 shares of the medical instruments supplier’s stock valued at $513,000 after purchasing an additional 3,400 shares in the last quarter. Federated Investors Inc. PA increased its position in shares of Sientra by 19,162.9% during the third quarter. Federated Investors Inc. PA now owns 66,457 shares of the medical instruments supplier’s stock valued at $1,587,000 after acquiring an additional 66,112 shares during the last quarter. Northern Trust Corp increased its position in shares of Sientra by 74.2% during the second quarter. Northern Trust Corp now owns 270,559 shares of the medical instruments supplier’s stock valued at $5,278,000 after acquiring an additional 115,283 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of Sientra during the third quarter valued at approximately $3,767,000. Finally, AQR Capital Management LLC increased its position in shares of Sientra by 41.5% during the third quarter. AQR Capital Management LLC now owns 19,345 shares of the medical instruments supplier’s stock valued at $462,000 after acquiring an additional 5,675 shares during the last quarter. Institutional investors own 92.79% of the company’s stock.
Sientra Company Profile (NASDAQ:SIEN)
Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
Featured Article: How to calculate the intrinsic value of a stock
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.